Gene expression has been studied in post-mortem frontal cortex samples
from patients who had suffered from schizophrenia and depressive illn
ess. mRNA was extracted and characterised by translation and separatio
n of the products by 2D gel electrophoresis. Post-mortem artefacts and
the agonal experience did not affect the size distribution or amount
of specific translation products. Four expression products were specif
ically reduced in samples from schizophrenics compared with normals. T
he expression of six products was altered in affective disorder, one i
n common with schizophrenia, two the same as in schizophrenia but incr
eased. cDNA libraries were produced from the mRNA samples and 5 clones
present at abnormal levels in schizophrenia identified by differentia
l screening, isolated and sequenced. All the sequences encode mitochon
drial transcripts; four encode mitochondrial rRNA and one the amino ac
id sequence of cytochrome oxidase sub-unit II. Increased cytochrome ox
idase transcripts were found in a further set of mRNA extracts from sc
hizophrenic patients including two who had not received neuroleptic me
dication. The effects of neuroleptic administration as exemplified by
ol-flupenthixol compared with the ineffective P-flupenthixol were stud
ied in experimental animals. It was found that 13 out of 28 clones who
se levels were altered were mitochondrial in origin including rRNA, CO
X I & II and the NADH-Q reductase. Those encoding respiratory enzymes
were at abnormally low levels as a result of ol-flupenthixol administr
ation. Measurements of the enzymic activity of cytochrome c oxidase in
post-mortem frontal cortex of schizophrenics did not indicate any dif
ferences in overall activity but there was a decreased sensitivity to
azide that was abolished by neuroleptics. Studies on NADH-cytochrome c
reductase showed that schizophrenics whether medicated or not had a r
educed rotenone sensitive activity that was compensated for by increas
ed rotenone insensitive activity. We conclude that changes in mitochon
drial gene expression are involved in schizophrenia and probably other
functional psychoses.